(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
10 day averaged volume of Cue Biopharma is 316690
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Wed May 2024 | 1.91 | 1.92 | 1.99 | 1.60 | 1.964 times |
| 30 Tue Apr 2024 | 1.90 | 1.40 | 1.98 | 1.37 | 3.983 times |
| 29 Mon Apr 2024 | 1.42 | 1.39 | 1.48 | 1.38 | 0.492 times |
| 26 Fri Apr 2024 | 1.37 | 1.40 | 1.44 | 1.32 | 0.835 times |
| 25 Thu Apr 2024 | 1.41 | 1.42 | 1.42 | 1.30 | 0.534 times |
| 24 Wed Apr 2024 | 1.42 | 1.53 | 1.58 | 1.38 | 1.009 times |
| 23 Tue Apr 2024 | 1.50 | 1.56 | 1.60 | 1.49 | 0.51 times |
| 22 Mon Apr 2024 | 1.57 | 1.55 | 1.60 | 1.49 | 0.572 times |
| 19 Fri Apr 2024 | 1.56 | 1.56 | 1.61 | 1.52 | 0.534 times |
| 18 Thu Apr 2024 | 1.58 | 1.64 | 1.65 | 1.56 | 0.535 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.9, but if it comes below 1.9, then a intra day sell could be more profitable.
If you take a sell trade below 1.9, then use 1.9 as stoploss and 1.66 as target. However if you take a buy trade in stock , then use 1.9 as stoploss and 2.1 as target.
Share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.37 |
| Downside Target | 1.47 |
| Downside Target | 1.60 |
| Downside Target | 1.65 |
| Downside Target | 1.74 |
| Upside Target | 1.95 |
| Upside Target | 1.99 |
| Upside Target | 2.08 |
| Upside Target | 2.23 |
| Upside Target | 2.55 |
| Upside Target | 2.69 |
| Upside Target | 3.20 |
Intraday share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Intraday Target | 1.52 |
| Downside Intraday Target | 1.14 |
| Upside Intraday Target | 2.14 |
| Upside Intraday Target | 2.38 |
| Downside Intraday Target | 1.76 |
Weekly technical analysis of Cue Biopharma (CUE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Wed May 2024 | 1.91 | 1.39 | 1.99 | 1.37 | 1.861 times |
| 26 Fri Apr 2024 | 1.37 | 1.55 | 1.60 | 1.30 | 0.928 times |
| 19 Fri Apr 2024 | 1.56 | 1.77 | 1.77 | 1.47 | 0.584 times |
| 12 Fri Apr 2024 | 1.75 | 1.90 | 2.08 | 1.65 | 1.748 times |
| 05 Fri Apr 2024 | 1.85 | 1.93 | 1.95 | 1.74 | 1.612 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Wed May 2024 | 1.91 | 1.92 | 1.99 | 1.60 | 0.091 times |
| 30 Tue Apr 2024 | 1.90 | 1.93 | 2.08 | 1.30 | 1.43 times |
| 28 Thu Mar 2024 | 1.89 | 2.12 | 2.23 | 1.76 | 0.864 times |
| 29 Thu Feb 2024 | 2.08 | 2.66 | 2.69 | 1.95 | 0.947 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.7 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.7 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.